| Dr Tighe Curtis Richardson, DO | |
|
2 Pillsbury St Ste 100, Concord, NH 03301-3549 | |
| (603) 224-2020 | |
| (603) 228-7061 |
| Full Name | Dr Tighe Curtis Richardson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 19 Years |
| Location | 2 Pillsbury St Ste 100, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093815656 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Ophthalmologic Associates Pa | 0547250920 | 15 |
News Archive
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).
Ingen Technologies, Inc., the leading manufacturer of in-line oxygen flow meters for respiratory medical devices, which helps companies similar to McKesson Corporation and Amedisys Inc. achieve substantial cost-savings by reducing support costs for in-home oxygen patients, recently announced that the company is set to expand into government and export markets.
A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer.
PeptiMed announced today that under a Material Transfer Agreement it will collaborate with the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), located at the Frederick National Laboratory of Cancer Research in Frederick, MD.
A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has found that controlling the levels of the TIP60 protein, which is a tumour suppressor, could potentially prevent the spread of breast cancer cells.
› Verified 2 days ago
| Entity Name | Concord Ophthalmologic Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831183268 PECOS PAC ID: 0547250920 Enrollment ID: O20040517001006 |
News Archive
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).
Ingen Technologies, Inc., the leading manufacturer of in-line oxygen flow meters for respiratory medical devices, which helps companies similar to McKesson Corporation and Amedisys Inc. achieve substantial cost-savings by reducing support costs for in-home oxygen patients, recently announced that the company is set to expand into government and export markets.
A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer.
PeptiMed announced today that under a Material Transfer Agreement it will collaborate with the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), located at the Frederick National Laboratory of Cancer Research in Frederick, MD.
A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has found that controlling the levels of the TIP60 protein, which is a tumour suppressor, could potentially prevent the spread of breast cancer cells.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tighe Curtis Richardson, DO 2 Pillsbury St Ste 100, Concord, NH 03301-3549 Ph: (603) 224-2020 | Dr Tighe Curtis Richardson, DO 2 Pillsbury St Ste 100, Concord, NH 03301-3549 Ph: (603) 224-2020 |
News Archive
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has received a request for proposal (RFP) from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA).
Ingen Technologies, Inc., the leading manufacturer of in-line oxygen flow meters for respiratory medical devices, which helps companies similar to McKesson Corporation and Amedisys Inc. achieve substantial cost-savings by reducing support costs for in-home oxygen patients, recently announced that the company is set to expand into government and export markets.
A study by the Columbia University Nova York, in collaboration with the Catalan Institute of Oncology , Belvitge Biomedical Research Institute (ICO-IDIBELL) has identified two new genes that lead to more aggressive forms of prostate cancer.
PeptiMed announced today that under a Material Transfer Agreement it will collaborate with the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), located at the Frederick National Laboratory of Cancer Research in Frederick, MD.
A team of researchers from the Cancer Science Institute of Singapore at the National University of Singapore has found that controlling the levels of the TIP60 protein, which is a tumour suppressor, could potentially prevent the spread of breast cancer cells.
› Verified 2 days ago
Maynard B Wheeler, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 248 Pleasant Street, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
Maxwell Arrington Snead Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 | |
Andre A D'hemecourt, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 100, Concord, NH 03301 Phone: 603-228-1104 Fax: 603-228-7061 | |
Christie L Morse, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Suite 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
David Alan Weinberg, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 1600, Concord Eye Care, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 | |
Bradford S Hall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St, Ste 1600, Concord, NH 03301 Phone: 603-224-2020 Fax: 603-228-0248 |